tofisopam has been researched along with Somatoform Disorders in 1 studies
tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksandrovskiĭ, IuA | 1 |
| Avedisova, AS | 1 |
| Pavlova, MS | 1 |
1 other study available for tofisopam and Somatoform Disorders
| Article | Year |
|---|---|
[Autonomic effect of grandaxin in the treatment of neurotic disorders in general somatic practice (lecture)].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Autonomic Nervous System; Benzodiazepines; Humans; Neuro | 1998 |